Overview
Emphasizes basic mechanisms of disease, translational and clinical principles of pulmonary hypertension and right ventricular dysfunction
Discusses controversies in PH disease management to provide the readership with balanced opinions on hot topics in the field
Serves as the state of the art text in pulmonary vascular disease by providing a comprehensive review of each pertinent and cutting-edge principle material to scientific to clinical domains within the field?
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (23 chapters)
-
Front Matter
-
Introduction
-
Front Matter
-
-
Basic Mechanism of Disease
-
Front Matter
-
-
Translational and Clinical Principles of Pulmonary Vascular Disease and Right Ventricular Dysfunction
-
Front Matter
-
-
Clinical Evaluation and Management of Pulmonary Hypertension
-
Front Matter
-
Keywords
About this book
Reviews
“This is a comprehensive book on the important clinical topic of pulmonary hypertension, and one of the most up to date on this emerging field of study. … The intended audience is specialists in the field of cardiology and pulmonology. … This book is useful for both clinicians and those interested in basic science and translational research.” (Shubhum Misra, Doody's Book Reviews, February, 2016)
Editors and Affiliations
About the editors
Bradley A. Maron, M.D. is an Assistant Professor of Medicine at Harvard Medical School (HMS), Associate Physician in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital, and Co-director of the Pulmonary Vascular Disease Center at the Boston VA Healthcare System. His research focuses on the basic mechanisms underpinning adverse pulmonary vascular remodeling. Dr. Maron’s research is funded by the NIH, among other prestigious foundations. He is also an Eleanor and Miles Shore Scholar in Medicine and HMS Excellence in Teaching award recipient.
Roham T. Zamanian, M.D. is an Assistant Professor of Medicine and Director of the Adult Pulmonary Hypertension Program at Stanford University School of Medicine. Dr. Zamanian completed medical school and Internal Medicine training at the University of California, Irvine Medical Center and fellowship in Pulmonary and Critical Care Medicine at Stanford University. Dr. Zamanian was also an eBay Pulmonary Vascular Disease super-fellow at the Vera Moulton Wall Center (VMWC) for Pulmonary Vascular Diseases at Stanford University. Besides an active clinical career, Dr. Zamanian is a translational scientist focusing on the discovery of novel biochemical and clinical risk factors for pulmonary vascular disease. Dr. Zamanian’s research is funded by the NIH and VMWC.
Aaron Waxman, M.D., Ph.D., is the Executive Director of the Center for Pulmonary Heart Diseases at the Brigham and Women’s Hospital (BWH) Heart and Vascular and Lung Centers. Dr. Waxman directs the Pulmonary Vascular Disease Program at BWH. His interests focus on integrating clinical and basic investigations to understand further pulmonary vascular disease and right heart failure. Dr. Waxman directs a robust NIH-funded clinical and basic research program, posts leadership roles in several international organizations, and collaborates actively with clinical experts and investigators around the world.
Bibliographic Information
Book Title: Pulmonary Hypertension
Book Subtitle: Basic Science to Clinical Medicine
Editors: Bradley A. Maron, Roham T. Zamanian, Aaron B. Waxman
DOI: https://doi.org/10.1007/978-3-319-23594-3
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2016
Hardcover ISBN: 978-3-319-23593-6Published: 10 November 2015
Softcover ISBN: 978-3-319-34785-1Published: 23 August 2016
eBook ISBN: 978-3-319-23594-3Published: 02 November 2015
Edition Number: 1
Number of Pages: XVI, 371
Topics: Cardiology, Pneumology/Respiratory System